about
Amylin at the interface between metabolic and neurodegenerative disordersEvolutionary science as a method to facilitate higher level thinking and reasoning in medical trainingHearing thresholds in adult Nigerians with diabetes mellitus: a case-control studyExercise in vivo marks human myotubes in vitro: Training-induced increase in lipid metabolism.Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?The prevalence of impaired fasting glucose and undiagnosed diabetes mellitus and associated risk factors among adults living in a rural Koladiba town, northwest Ethiopia.Sex specific incidence rates of type 2 diabetes and its risk factors over 9 years of follow-up: Tehran Lipid and Glucose StudyEffect of baseline HbA1c level on the development of diabetes by lifestyle intervention in primary healthcare settings: insights from subanalysis of the Japan Diabetes Prevention Program.The effect of slow spaced eating on hunger and satiety in overweight and obese patients with type 2 diabetes mellitusA systematic review of glomerular hyperfiltration assessment and definition in the medical literature.Efficacy and cost-effectiveness of a web-based intervention with mobile phone support to treat depressive symptoms in adults with diabetes mellitus type 1 and type 2: design of a randomised controlled trial.Toward integrated and sustainable prevention against diabetes in rural China: study rationale and protocol of eCROPS.Natural environments, ancestral diets, and microbial ecology: is there a modern "paleo-deficit disorder"? Part I.GRK5 intronic (CA)n polymorphisms associated with type 2 diabetes in Chinese Hainan IslandAcute effects of exposure to a traditional rural environment on urban dwellers: a crossover field study in terraced farmland.Association between obesity and depression in patients with diabetes mellitus type 2; a study protocol.Comparison of the efficacy of liraglutide with pioglitazone on dexamethasone induced hepatic steatosis, dyslipidemia and hyperglycaemia in albino rats.Impaired adipose tissue expandability and lipogenic capacities as ones of the main causes of metabolic disorders.Adherence to Two Methods of Education and Metabolic Control in Type 2 Diabetics.Variations in levels of IL-6 and TNF-α in type 2 diabetes mellitus between rural and urban Ashanti Region of Ghana.Nutritional systems biology of type 2 diabetesValidating prediction scales of type 2 diabetes mellitus in Spain: the SPREDIA-2 population-based prospective cohort study protocol.Leptin Production by Encapsulated Adipocytes Increases Brown Fat, Decreases Resistin, and Improves Glucose Intolerance in Obese MiceEfficacy of bromocriptine on glycemic and metabolic control of prediabetic patients.Association between IGF2BP2 Polymorphisms and Type 2 Diabetes Mellitus: A Case-Control Study and Meta-AnalysisEnhancing in vivo survival of adipose-derived stromal cells through Bcl-2 overexpression using a minicircle vectorValidation of Type 2 Diabetes Risk Variants Identified by Genome-Wide Association Studies in Northern Han Chinese.Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes.Early mitochondrial dysfunction in glycolytic muscle, but not oxidative muscle, of the fructose-fed insulin-resistant rat.6-Paradol and 6-Shogaol, the Pungent Compounds of Ginger, Promote Glucose Utilization in Adipocytes and Myotubes, and 6-Paradol Reduces Blood Glucose in High-Fat Diet-Fed Mice.Design of an amide N-glycoside derivative of β-glucogallin: a stable, potent, and specific inhibitor of aldose reductase.Characteristics of Chinese herbal medicine usage in ischemic heart disease patients among type 2 diabetes and their protection against hydrogen peroxide-mediated apoptosis in H9C2 cardiomyoblasts.Involvement of TonEBP/NFAT5 in osmoadaptative response of human retinal pigmented epithelial cells to hyperosmolar stress.Effects of benchmarking on the quality of type 2 diabetes care: results of the OPTIMISE (Optimal Type 2 Diabetes Management Including Benchmarking and Standard Treatment) study in Greece.Therapeutic Actions of the Thiazolidinediones in Alzheimer's Disease.Metformin Treatment Prevents Sedentariness Related Damages in Mice.Can a simple test of functional capacity add to the clinical assessment of diabetes?PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice.Trialling of an optimal health programme (OHP) across chronic disease.Glucagon secretion from pancreatic α-cells.
P2860
Q27003342-4B2A8CDB-450A-4626-B778-D56756C7010BQ27928021-9333144B-C6B0-4C39-A307-385D04028AB2Q30356853-773096C4-DD08-49CC-9363-833BA8856E03Q33558855-EDFEF93F-71C5-4DE1-A4C7-B7CEDD89C247Q33776187-3D2BF690-1B42-42E7-A72D-666991529942Q33883452-BEBC3AF1-09D0-4F04-96CC-19E880856206Q33910878-8F07848A-5DD3-4C60-8DD8-470A179E3A0BQ34419127-32882B80-5B50-497B-8BF6-F7A2B3ECE020Q34419160-02D22C15-D709-4D2C-BC13-E810131BA47FQ34457150-B0264B58-36A9-46CD-9B48-86637A84A6DFQ34478622-6D9B96F7-4FCD-43EB-87AD-572CC6C88935Q34898480-36DCF4E8-EAD1-433B-9518-CD9A177862D7Q35052856-8F4E2ABB-C30C-4E51-869C-DDE55C85CD23Q35110729-0AD21783-09C8-4B48-8C91-EB896C7A178DQ35131746-9E887CC5-7598-475A-A16E-24F1FE78F264Q35173316-AD1E1A03-4705-4690-9B23-E84B36F5A8E8Q35276899-40C13D3C-92EA-46A9-A198-F90E1B0C4F1AQ35438444-4399A6A5-4D95-479A-BB28-B7179864D3C5Q35772987-AFB7398D-6CD5-4D30-99D1-D7B7ABF115D9Q35782503-74536301-6CB7-4EF2-86FF-BEC69C1F0D22Q35883431-597BA369-AA66-4A31-A50A-9EEAE7F46C87Q35906741-6AE467AE-002F-4E91-A19E-5088F5EDCC74Q35982905-0F1E74F8-E61E-401C-8978-55F64B409B76Q36560960-E16073E1-487D-462F-A608-10F03758B263Q37044783-1172CF30-0000-4B3E-BACA-CE2F4E8C2980Q37124564-6DF330FF-873C-4B55-8E1C-C5E9A503F136Q37283671-18E166DB-2033-455D-AFB3-31E81BB89800Q37337259-7F7809C5-D954-4D47-81F3-5EDE22F96841Q37629051-7C94C68F-9B5F-4DC6-B84E-E21FCF861738Q37631637-3B4E4A91-9AC9-4DEC-9E62-D7D5470A1DB1Q37641604-35984BC6-6704-4459-B2D6-546EE7D69B9BQ37716571-6763DAAF-068E-4C87-A8D0-D0A86425D6FBQ38283375-3EF470EA-0044-4B14-BBBF-D7D16BD69494Q38402322-355F9F4F-8E1E-4B1B-B7F3-9920F8790CBBQ38639674-507494C9-2A53-4E10-A124-98B574EC2E3BQ38809599-880EA5E9-CC6A-44F9-B98A-1FE6D8B370F5Q41102081-61760054-1E29-4BAE-B713-4B6EDCC77600Q41913523-471D5E9D-9B17-4DBD-934B-8439098B5445Q42396354-EFD13B10-7317-456D-A71A-DAB3EAF4B33AQ42491341-1B319D16-09A3-4CCE-B146-3A14485E7C98
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Type 2 diabetes mellitus, pandemic in 21st century.
@ast
Type 2 diabetes mellitus, pandemic in 21st century.
@en
type
label
Type 2 diabetes mellitus, pandemic in 21st century.
@ast
Type 2 diabetes mellitus, pandemic in 21st century.
@en
prefLabel
Type 2 diabetes mellitus, pandemic in 21st century.
@ast
Type 2 diabetes mellitus, pandemic in 21st century.
@en
P1476
Type 2 diabetes mellitus, pandemic in 21st century
@en
P2093
Emil Ginter
Vlado Simko
P356
10.1007/978-1-4614-5441-0_6
P407
P577
2012-01-01T00:00:00Z